| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |